Axinn Advises McKesson on $875M Acquisition of Rx Savings Solutions
September 19, 2022
Axinn is representing McKesson Corporation (NYSE: MCK), a diversified health care services leader, in its $875M acquisition of Rx Savings Solutions, a prescription price transparency and benefit insight company. Announced on September 19, 2022, the acquisition will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. The Axinn team is led by partners Daniel Bitton and Jeny Maier, and assisted by associate Neelesh Moorthy.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ABA 73rd Annual Section of Antitrust Law Spring Meeting
Speaking Engagement
Antitrust
CompLaw Nordic 2025
Sponsorship
Antitrust
GCR Live Cartels: 2025
Speaking Engagement
Antitrust
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
Consumer Brands CPG Legal Forum 2025
Speaking Engagement
Antitrust
2025 Why Antitrust: Everything You Need to Know About a Career in Antitrust Law
Speaking Engagement
Antitrust
Competition Law Developments in Germany: Three Things We Are Watching
Axinn Viewpoints
Antitrust
Noerr Competition Day 2025
Speaking Engagement
Antitrust
Who’s Blocking Me? Competition Law Issues With Healthcare Information Blocking
Axinn Viewpoints
Antitrust
Daniel Oakes, Tiffany Rider, and Lindsey Strang Aberg Win “Law360 Distinguished Legal Writing Award”
Awards & Recognitions
Antitrust